R. Willemze

5.9k total citations · 1 hit paper
129 papers, 4.3k citations indexed

About

R. Willemze is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, R. Willemze has authored 129 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 43 papers in Genetics and 33 papers in Immunology. Recurrent topics in R. Willemze's work include Acute Myeloid Leukemia Research (39 papers), Hematopoietic Stem Cell Transplantation (37 papers) and Chronic Lymphocytic Leukemia Research (27 papers). R. Willemze is often cited by papers focused on Acute Myeloid Leukemia Research (39 papers), Hematopoietic Stem Cell Transplantation (37 papers) and Chronic Lymphocytic Leukemia Research (27 papers). R. Willemze collaborates with scholars based in Netherlands, Italy and France. R. Willemze's co-authors include Willem E. Fibbe, Sicco A. Scherjon, Willy A. Noort, Humphrey H.H. Kanhai, Frans H.J. Claas, R. Otter, J. Hermans, J.H. Frederik Falkenburg, JH Falkenburg and Hanneke C. Kluin‐Nelemans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

R. Willemze

126 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

2003 590 citations R. Willemze, Willem E. Fibbe et al. Blood profile →

Peers

Countries citing papers authored by R. Willemze

Since Specialization

Citations

This map shows the geographic impact of R. Willemze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Willemze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Willemze more than expected).

Fields of papers citing papers by R. Willemze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Willemze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Willemze. The network helps show where R. Willemze may publish in the future.

Co-authorship network of co-authors of R. Willemze

This figure shows the co-authorship network connecting the top 25 collaborators of R. Willemze. A scholar is included among the top collaborators of R. Willemze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Willemze. R. Willemze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype 2018 ·Haematologica ·Frédéric Baron, Marian Stevens‐Kroef, Michal Kiciński, Giovanna Meloni, Petra Muus, Jean‐Pierre Marie, Constantijn J.M. Halkes, Xavier Thomas, Radovan Vrḫovac, Francesco Albano, François Lefrère, Simona Sica, Marco Mancini, Adriano Venditti, Anne Hagemeijer, Joop H. Jansen, Sergio Amadori, Théo de Witte, R. Willemze, Stefan Suciu	7
2	Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation 2007 ·Haematologica ·Erik W.A. Marijt, Amon R. Wafelman, (unknown), Cornelis A.M. van Bergen, (unknown), (unknown), (unknown), (unknown), (unknown), R. Willemze, F. Falkenburg	36
3	Human Mesenchymal Stem Cells Derived from Bone Marrow Display a Better Chondrogenic Differentiation Compared with Other Sources 2007 ·Connective Tissue Research ·Maria Ester Bernardo, Joyce Emons, Marcel Karperien, Alma J. Nauta, R. Willemze, Helene Roelofs, Salvatore Romeo, Antonio Marchini, Gudrun Rappold, Slobodan Vukičević, Franca Locatelli, Willem E. Fibbe	97
4	Proteolytic Enzyme Levels Are Increased During Granulocyte Colony-Stimulating Factor-Induced Hematopoietic Stem Cell Mobilization in Human Donors but Do Not Predict the Number of Mobilized Stem Cells 2002 ·Journal of Hematotherapy & Stem Cell Research ·Ronald van Os, Marianke L.J. van Schie, R. Willemze, Willem E. Fibbe	20
5	Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia 2002 ·Bone Marrow Transplantation ·Michel van Agthoven, (unknown), LF Verdonck, Bob Löwenberg, A Schattenberg, Machteld Oudshoorn, Anton Hagenbeek, (unknown), (unknown), R. Willemze	47
6	CAMPATH-1 antibodies in stem-cell transplantation 2001 ·Cytotherapy ·G Hale, Stephen Cobbold, Nicolás Novitzky, Donald Bunjes, R. Willemze, H. G. Prentice, D Milligan, Stephen Mackinnon, Herman Waldmann	35
7	Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914) 2001 ·British Journal of Haematology ·Pieter Sonneveld, Stefan Suciu, (unknown), Meral Beksaç, R Neuwírtová, G. Solbu, H M Lokhorst, J. van der Lelie, Hartmut Döhner, H Gerhartz, Christine M. Segeren, R. Willemze, Bob Löwenberg	66
8	Antibodies to the beta 2-integrins LFA-1 and Mac-1 synergistically enhance stem cell mobilization induced by G-CSF 1999 ·Experimental Hematology ·Gerjo A. Velders, Hans Pruijt, Ronald van Os, Yvette van Kooyk, Carl G. Figdor, R. Willemze, W.E. Fibbe	1
9	Selective Response of CD5+B Cell Malignancies to Activation of the CD72 Antigen 1998 ·Clinical Immunology and Immunopathology ·(unknown), H. Van de Velde, JH Falkenburg, Kris Thielemans, R. Willemze, Hanneke C. Kluin‐Nelemans	2
10	No expression of LFA-1 on murine hematopoietic progenitor cells with colony-forming or radioprotective capacity 1997 ·Blood ·Hans Pruijt, Carl G. Figdor, Yvette van Kooyk, R. Willemze, W.E. Fibbe	3
11	Mechanisms of stem cell mobilization in mice 1997 ·Experimental Hematology ·W.E. Fibbe, Hans Pruijt, L. Laterveer, Carl G. Figdor, Ghislain Opdenakker, R. Willemze	1
12	TCRγ δ+ cells expressing Vγ 9Vδ 2, which normally predominate the blood, are found in the spleens of patients with hairy cell leukemia 1997 ·Leukemia ·Lisette van de Corput, (unknown), (unknown), R. Willemze, Hanneke C. Kluin‐Nelemans	14
13	In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene 1995 ·Annals of Hematology ·Alexander P.A. Stegmann, M. Willy Honders, A Hagemeijer, Barbara Hoebee, R. Willemze, J. E. Landegent	30
14	Biology and treatment of myelodysplastic syndromes — developments in the past decade 1993 ·Annals of Hematology ·R. Willemze, Willem E. Fibbe, JH Falkenburg, Hanneke C. Kluin‐Nelemans, P. M. Kluin, J. E. Landegent	21
15	Assignment of the Human Deoxycytidine Kinase (DCK) Gene to Chromosome 4 Band q13.3-q21.1 1993 ·Genomics ·Alexander P.A. Stegmann, M. Willy Honders, (unknown), J. Wessels, R. Willemze, J. E. Landegent	8
16	Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists 1992 ·Annals of Hematology ·Jan W. Gratama, M. A. P. Oosterveer, (unknown), Willem E. Fibbe, Olle Ringdén, Jaak M. Vossen, R. Willemze, R. L. H. Bolhuis, J. J. van Rood, Ingemar Ernberg	8
17	Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin 1990 ·Infection ·H. F. L. Guiot, J.W.M. van der Meer, R. van Furth, W Peters, P.J. van den Broek, R. Willemze, J. A. Kramps	36
18	Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia 1988 ·Annals of Hematology ·W Peters, R. Willemze, F. E. Zwaan, L. P. Colly	7
19	Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas. 1985 ·PubMed ·Meijer Cj, R. Willemze, H. Mullink, (unknown), (unknown)	1
20	Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia 1978 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), R. Willemze, Eernisse Jg, A Brand, van Rood Jj, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact